RecruitingNCT01731353
FungiScope - A Global Emerging Fungal Infection Registry
Sponsor
University of Cologne
Enrollment
1,000 participants
Start Date
Mar 1, 2003
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.
Eligibility
Inclusion Criteria1
- Cultural, histopathological, antigen or DNA evidence of invasive fungal infection
Exclusion Criteria3
- Infection due to Candida spp., Cryptococcus neoformans, Pneumocystis jiroveci
- Endemic fungal infection such as coccidioidomycosis or histoplasmosis
- Colonisation or other non-invasive infection
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01731353
Related Trials
Immunomonitoring of Mold Invasive Infections
NCT062851881 location
Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD（ Breakthrough Invasive Fungal Disease） in Patients With Malignant Hematological Diseases
NCT071357781 location
Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease
NCT068194101 location
Fungus-specific immune cells for bone marrow transplant patients with invasive fungal disease
ACTRN126180015402024 locations